Bookmark
Forward
Acquired MET-DSTN Fusion Mediated Resistance to EGFR-TKIs in Lung Adenocarcinoma and Responded to Crizotinib Plus Gefitinib: A Case Report.
Yalun Li, Ke Wang, Panwen Tian, Weimin Li
Clinical lung cancer 2022 Jan
Sizes of these terms reflect their relevance to your search.
No abstract available.
Citation
Yalun Li, Ke Wang, Panwen Tian, Weimin Li.
Acquired MET-DSTN Fusion Mediated Resistance to EGFR-TKIs in Lung Adenocarcinoma and Responded to Crizotinib Plus Gefitinib: A Case Report.
Clinical lung cancer.
2022 Jan;23(1):e83-e86
Mesh Tags
Adenocarcinoma of Lung
Carcinoma, Non-Small-Cell Lung
Crizotinib
Destrin
ErbB Receptors
Female
Gefitinib
Humans
Lung Neoplasms
Middle Aged
Mutation
Oncogene Proteins, Fusion
Protein-Tyrosine Kinases
Proto-Oncogene Proteins c-met
Substances
DSTN protein, human
Destrin
Oncogene Proteins, Fusion
Crizotinib
EGFR protein, human
ErbB Receptors
MET protein, human
Protein-Tyrosine Kinases
Proto-Oncogene Proteins c-met
Gefitinib
PMID: 34802880
View Full Text